EFFECTIVE BOWEL CLEANSING FOR SCREENING COLONOSCOPY
https://doi.org/10.33878/2073-7556-2020-19-3-65-71
Abstract
AIM: to assess the effectiveness and safety of sodium picosulfate for screening colonoscopy.
PATIENTS AND METHODS: the retrospective study included 299 patients at mean age of 54±14 years who had screening colonoscopy, . All patients received sodium pikosulfate for bowel cleansing. The quality of bowel cleansing was evaluated by the Boston international scale. Organoleptic and subjective sensations were also evaluated.
RESULTS: the quality of bowel cleansing was 8.5±1.0 point by Boston scale. As a result of screening colonoscopy in 96 (32.1%) patients, polyps of the rectum, sigmoid, colon and ileum were detected in 11%, 8%, 11% and 2% of cases respectively. Pathology showed that 78 (26%) patients had adenomatous polyps, 13 (4%) – adenocarcinoma. All patients reported comfortable use of the agent.
CONCLUSION: sodium picosulfate fully meets the requirements for the drug used for bowel cleansing for colonoscopy.
About the Authors
L. G. Vologzhanina
Academician Ye.A. Vagner Perm State Medical University
Russian Federation
Russian Federation
Lyudmila G. Vologzhanina
Petropavlovskaya str., 26, Perm, 614990
O. A. Igumnova
Academician Ye.A. Vagner Perm State Medical University
Russian Federation
Russian Federation
Oksana A. Igumnova
Petropavlovskaya str., 26, Perm, 614990
I. V. Petukhova
Academician Ye.A. Vagner Perm State Medical University
Russian Federation
Russian Federation
Irina V. Petukhova
Petropavlovskaya str., 26, Perm, 614990
P. K. Sannikov
Academician Ye.A. Vagner Perm State Medical University
Russian Federation
Russian Federation
Pavel K. Sannikov
Petropavlovskaya str., 26, Perm, 614990
References
1. Aliev F.Sh., Desiatov F.Sh., Krutskih A.G. et al. Epidemiologia kolorektalnogo raka : mirovie i regionalnie tendencii. Medicinskaya nauka i obrazovanie Yrala. 2016; no. 4, pp. 125-128. (In Russ).
2. Tryakin A.A., Artamonova E.V., Bolotina L.V. et al. Practicheskie rekomendacii po lekarstvennomy lecheniu raka obodochnoi kishki. Zlokachestvennie opyholi. 2016; no. 4 Specvip. 2, pp. 248-265. (In Russ).
3. Fedorov V.E., Podeliakin K.A. Epidemiological aspects of colorectal cancer. Medicinskiy almanac. 2017; no. 4 (49), pp. 145-148. (In Russ).
4. American Cancer Society. Global Cancer Facts & Figures 3rd Edition. 2015 [Электронный ресурс]. URL: https://www.cancer.org/cancer/colon-rectal-cancer/about/what-is-colorectal-cancer.html.
5. National Cancer Institute. Colorectal cancer. 2017 [Электронный ресурс]. URL: ttps://www.cancer.gov/types/colorectal.
6. Rembacken B, Hassan C, Riemann J et al. Quality in screening colonoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE). Endoscopy. 2012;44(10):957-968.
7. Frisch M. Population-based study from Denmark and Sweden. Cancer Rec. 1999;59(3):753-756
8. Kaprin A.D., Starinskii V.V., Petrova G.V. Zlocachestvennie novoobrazovania v Rossii v 2015 g. 2015; 250 p. (In Russ).
9. Borsuk A.D. Skrining kolorektalnogo raka (obzor literaturi). Problemi zdorovia i ekologii. 2014; no. 3 (41), pp. 56-61.
10. Winawer SJ. et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993;329:1977-1981.
11. Hewitson Р. et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103:1541-1549.
12. Markowitz GS. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure. J Am Soc Nephrol. 2005;16(11):3389-3396.
13. Winawer S, Zauber A, O’Brien M et al. Randomized Comparison of Surveillance Intervals after Colonoscopic Removal of Newly Diagnosed Adenomatous Polyps. New England Journal of Medicine. 1993;328(13):901906.
14. Brenner H. et al. Does a negative screening colonoscopy ever need to be repeated? Gut. 2006;55:1145-1150.
15. Singh II, Turner D, Xue L. et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA. 2006;295:23662373.
16. Liebennan DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007;133:1077-1085.
17. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectalcancer incidence and mortality after lower endoscopy. N Engl J Med. 2013 Sep 19;369(12):1095-1105. DOI: 10.1056/NEJMoa1301969
18. Singh II. et al. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA. 2006;295:2366-2373.
19. Rijn JC. et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101:343-350.
20. Kashin S.V., Nechaikova N.V. Quality indicators in screening colonoscopy for colorectal polyps and cancer. Russian journal of Evidence-based gastroenterology. 2016; no. 2, pp. 13-21. (In Russ).
21. Fletcher R, Nadel M, Allen J et al. The Quality of Colonoscopy Services – Responsibilities of Referring Clinicians. J GEN INTERN MED. 2010;25(11):1230-4. DOI: 10.1007/s11606-010-1446-2
22. Calderwood A., Jacobson B. Comprehensive validation of the Boston Bowel Preparation Scale. Gastrointestinal Endoscopy. 2010;72(4):686692.
23. DiPalma JA, Marshall JB. Comparison of a new sulfate-free polyethylene glycol electrolyte lavage solution versus a standard solution for colonoscopy cleansing. Gastrointest Endoscopy. 1990;36(3):285-289.
24. Halphen M, Heresbach D, Gruss HJ. et al. Validation of the Harefield Cleansing Scale: a tool for the evaluation of bowel cleansing quality in both research and clinical practice. Gastrointest Endoscopy. 2013;78:12131.
25. Scherbakov P.L., Parfenov P.L., Albulova E.V. New schemes of preparation of the intestine for colonoscopy. Lechashii vrach. 2014; no. 11,pp. 75-80. (In Russ).
26. Florentin M, Liamis G, Elisaf MS. Colonoscopy preparationinduced disorders in renal function and electrolytes. World J Gastrointest Pharmacol Therapy. 2014;5(2):50-54.
27. Hurst FP, Bohen EM, Osgard EM. et al. Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol. 2007;18(12):3192-3198.
28. Instructions for medicinal use Picoprep® (LP 002537-16.07.2014).
29. Lai EJ, Calderwood AH, Doros G. et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopyoriented research. Gastrointest Endoscopy. 2009;69:620-625.
30. Liebennan DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007;133:1077-1085.
31. Macleod AJ, Duncan KA, Pearson RH. et al. A comparison of Fleet Phospho-soda with Picolax in the preparation of the colon for double contrast barium enema. Clin Radiol. 1998;53(8):612-614.
32. Tan JJ, Tjandra JJ. Which is the optimal bowel preparation for colonoscopy – a meta-analysis. Colorectal Dis. 2006;8(4):247-258.
33. David A. Johnson et al. Optimizing Adequacy of Bowel Cleansing for Colonoscopy: Recommendations From the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2014;147:903-924.
34. Obuchaushaya programma [electronnii resurs]: Regim dostupa: www.cori.org/bbps/ (In Russ).
Review
For citations:
Vologzhanina L.G., Igumnova O.A., Petukhova I.V., Sannikov P.K. EFFECTIVE BOWEL CLEANSING FOR SCREENING COLONOSCOPY. Koloproktologia. 2020;19(3):65-71. (In Russ.) https://doi.org/10.33878/2073-7556-2020-19-3-65-71
Views:
579
Email this article 
